0 rating

Pediatric Rheumatology

Dolezalova P, Price-Kuehne FE, Özen S et al.

Charles University, Prague, Czech Republic.

 Ann Rheum Dis 2013;72:1628–33.

Lucía Silva’s review: Systemic vasculitides are rare in children. These conditions are associated with substantial morbidity and mortality, but the evaluation of treatment efficacy is hindered by the absence of a standardized assessment tool. Therefore, the authors of this study aimed to develop and validate a pediatric vasculitis activity assessment tool based on modification of the Birmingham Vasculitis Activity Score (BVAS) version 3. Compatibility with the BVAS will allow the long-term follow-up of children into adulthood and the inclusion of pediatric patients in clinical trials.

Return to top